Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Sales | 142,824 | 118,514 | 109,374 | 79,707 | 59,867 |
Cost of Goods | 38,139 | 32,681 | 30,733 | 27,020 | 13,171 |
Gross Profit | 104,685 | 85,833 | 78,641 | 52,687 | 46,696 |
Operating Expenses | 94,971 | 88,503 | 83,470 | 86,224 | 45,149 |
Operating Income | 9,853 | -1,989 | -4,096 | -33,517 | 1,718 |
Other Income | 675 | -645 | 417 | -1,693 | -1,771 |
Pre-tax Income | 10,528 | -2,634 | -3,679 | -35,210 | -53 |
Income Tax | -26,005 | -1,398 | 70 | 544 | 193 |
Net Income Continuous | 36,533 | -1,236 | -3,749 | -35,754 | -246 |
Net Income Discontinuous | 368 | 10,021 | N/A | N/A | -1,543 |
Net Income | $36,901 | $8,785 | $-3,749 | $-35,754 | $-1,789 |
EPS Basic Total Ops | 1.07 | 0.25 | -0.11 | -1.04 | -0.05 |
EPS Basic Continuous Ops | 1.06 | -0.04 | -0.11 | -1.04 | -0.01 |
EPS Basic Discontinuous Ops | 0.01 | 0.29 | N/A | N/A | -0.04 |
EPS Diluted Total Ops | 1.07 | 0.25 | -0.11 | -1.04 | -0.05 |
EPS Diluted Continuous Ops | 1.06 | -0.04 | -0.11 | -1.04 | -0.01 |
EPS Diluted Discontinuous Ops | 0.01 | 0.29 | N/A | N/A | -0.04 |
EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | N/A | -0.01 |
EBITDA(a) | $10,726 | $-1,301 | $-3,103 | $-32,482 | $2,658 |